zepbound tirzepatide patent expiration date Zepbound: Package Insert / Prescribing Information / MOA FDA approval for Zepbound (tirzepatide)

McCarty MF

Circulation 2018;137:2200-2

Ozempic, known generically as semaglutide, is an injectable medicine that functions as a GLP-1 receptor agonist

Semaglutide delays gastric emptying as part of its weight-loss mechanism

The knees, hips, ankles, and lower back must adjust to reduced load, and connective tissues like ligaments and tendons can become temporarily inflamed or sore during this transition

Our latest blog covers how Pharmacy Benefit Administration helps plan sponsors gain better visibility, strengthen clinical oversight, and manage high-cost and specialty drug utilization before it becomes a budget problem